logo
Plus   Neg
Share
Email

Conatus Pharmaceuticals Posting Strong Gain In Afternoon Trading

Shares of Conatus Pharmaceuticals (CNAT) have shown a strong move to the upside on Friday, with the biotechnology company climbing by 7.9 percent. Conatus reached a nearly two-month intraday high earlier in the session.

The jump by Conatus comes after the company announced that its exclusive license with Novartis (NVS) for the global development and commercialization of emricasan has become effective upon the receipt of a $7 million payment.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The United Auto Workers union reportedly plans to go on strike against auto giant General Motors Co. (GM) after both the parties failed to reach a tentative deal before a Saturday deadline. According to CNBC, the strike has been called despite GM saying it presented a "strong offer" to the union.... Millennials and Generation Zs, or people aged between 18 to 34 year, pay more for car repairs, according to a new survey. The average American spent $1,986 over the past five years on vehicle repairs and maintenance, according to a survey by Ally Financial conducted by Harris Poll. However, among... Gap Inc.'s (GPS) Old Navy brand announced plans to open 800 new stores as part of its upcoming split from its parent company. "We'll almost double our fleet to 2,000 stores in North America, predominantly in under-served small markets," Old Navy CEO Sonia Syngal said. The company said the plan was...
Follow RTT